LIF’s Board Directors Guillermo Cleti and Daniel Salomón had a meeting with Mauricio Monsalvo (REMEDIAR Program’s General Coordinator), Jorge Zarzur (Executive Director of the National Program of State Production of Medicines, Vaccines and Medical Devices) and Maximiliano Derecho (Legal Advisor - National Program for the Control of Drugs and Medical Devices Market - ANMAT).
The meeting took place at the National Health Ministry in Buenos Aires where they talked about the next LIF’s production of medicines for the second half of the 2014.
Since December 2013, LIF has produced different medicines for the treatment of chronic diseases as diabetes (Glibenclamide and Metformin), hypertension (Enalapril) and High Cholesterol (Simvastatin).
Antibiotics (Amoxicillin and Cefalexin) and Analgesics (Paracetamol) are.more medicines that are going to be produced by LIF.
The National Health Ministry wants to continue with the provision of these medicines in more than 7000 CAPS throughout the country.
REMEDIAR Program is a national program that provides medicines to almost 7000 CAPS (Primary Health Centres) of Argentina.
ANMAT: Administración Nacional de Medicamentos, Alimentos y Tecnología Médica. (National Regulatory Agency for medicines, food and medical devices).
CAPS (Primary Health Centres)
No comments:
Post a Comment